Skip to content
Search

Latest Stories

Pharmacy Schools Council revises statute to prioritise equality, diversity and inclusion

In a symbolic step forward, the Pharmacy Schools Council (PhSC) has updated its constitution to reflect parity in terms of representations based on gender, ethnicity and geography.

The council said it has done so to ensure that leadership within the profession is equitable, diverse and inclusive.


"Breaking down barriers to accessing leadership positions forms part of the organisation’s ongoing work to ensure that diversity is actively championed within the profession," PhSC said in a statement.

In addition to the three nominated executive officers, the council’s executive body may now appoint a further two executive officers to ensure that UK pharmacy schools are well represented.

Furthermore, PhSC members may only serve on the executive as chair, deputy chair or executive officer for a maximum of two three-year terms to ensure a regular turnover of new members.

Commenting on the revised constitution, Professor Duncan Craig, chair of the PhSC, said: “Pharmacy schools take seriously their commitment to promoting equality, diversity and inclusion and it is therefore only right that this should be reflected in the Pharmacy Schools Council’s constitution.

"It is essential that we make every effort to ensure that diverse viewpoints are being represented and heard at all levels of decision making and in leadership positions.

“Removing barriers will help to build a profession which is diverse, highly capable and representative of the communities it serves. We look forward to engaging with other ways in which we can drive positive change throughout UK Schools of Pharmacy”.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less